// App-Quantinova.ai

VPB0131 : Exogenous estrogen use for contraception and hormone replacement therapy and the risk of thrombosis in women with COVID-19

Researchers

Presenter

  • J. Sabile

Principal Investigators

  • H. McMurry

  • T. Kartika

  • J. Shatzel

Medical Centers

  • Oregon Health and Science University, Portland, Oregon, United States

  • Oregon Health and Science University, Portland, Oregon, United States

  • Oregon Health and Science University, Portland, Oregon, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Pulmonary/Respiratory Diseases

  • Infectious Diseases (ID)

  • Blood/haematological Diseases

Disease

  • Ischemic stroke

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved